A detailed history of Crossmark Global Holdings, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 36,455 shares of VTRS stock, worth $378,402. This represents 0.01% of its overall portfolio holdings.

Number of Shares
36,455
Previous 35,627 2.32%
Holding current value
$378,402
Previous $386,000 12.69%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$11.27 - $13.53 $9,331 - $11,202
828 Added 2.32%
36,455 $435,000
Q3 2023

Nov 08, 2023

SELL
$9.59 - $11.35 $527 - $624
-55 Reduced 0.15%
35,627 $343,000
Q2 2023

Jul 31, 2023

SELL
$9.02 - $10.29 $1,569 - $1,790
-174 Reduced 0.49%
35,682 $371,000
Q1 2023

May 12, 2023

BUY
$9.2 - $12.26 $6,504 - $8,667
707 Added 2.01%
35,856 $345,000
Q4 2022

Jan 19, 2023

BUY
$8.72 - $11.56 $33,101 - $43,881
3,796 Added 12.11%
35,149 $392,000
Q3 2022

Nov 01, 2022

SELL
$8.48 - $11.13 $1,110 - $1,458
-131 Reduced 0.42%
31,353 $267,000
Q2 2022

Jul 29, 2022

BUY
$9.95 - $12.27 $6,049 - $7,460
608 Added 1.97%
31,484 $329,000
Q1 2022

May 11, 2022

SELL
$9.81 - $15.4 $186 - $292
-19 Reduced 0.06%
30,876 $336,000
Q4 2021

Jan 10, 2022

SELL
$12.09 - $14.68 $502,569 - $610,232
-41,569 Reduced 57.37%
30,895 $418,000
Q3 2021

Oct 21, 2021

BUY
$13.25 - $15.13 $960,148 - $1.1 Million
72,464 New
72,464 $982,000
Q3 2021

Oct 13, 2021

SELL
$13.25 - $15.13 $948,885 - $1.08 Million
-71,614 Closed
0 $0
Q2 2021

Jul 21, 2021

BUY
$12.97 - $16.15 $9,403 - $11,708
725 Added 1.02%
71,614 $1.02 Million
Q1 2021

Apr 15, 2021

SELL
$13.59 - $18.54 $81,308 - $110,924
-5,983 Reduced 7.78%
70,889 $990,000
Q4 2020

Jan 14, 2021

BUY
$14.3 - $18.74 $1.1 Million - $1.44 Million
76,872 New
76,872 $1.44 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.